Literature DB >> 366410

Decreased vascular prostacyclin in juvenile-onset diabetes.

K Silberbauer, G Schernthaner, H Sinzinger, H Piza-Katzer, M Winter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 366410

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  25 in total

1.  Changes in cardiovascular sensitivity of alloxan-treated diabetic rats to arachidonic acid.

Authors:  A L Boura; W C Hodgson; R G King
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

Review 2.  Molecular insights and therapeutic targets for diabetic endothelial dysfunction.

Authors:  Jian Xu; Ming-Hui Zou
Journal:  Circulation       Date:  2009-09-29       Impact factor: 29.690

3.  Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin.

Authors:  Rolf P Kreutz; Perry Nystrom; Yvonne Kreutz; Jia Miao; Richard Kovacs; Zeruesenay Desta; David A Flockhart; Yan Jin
Journal:  Platelets       Date:  2012-03-02       Impact factor: 3.862

Review 4.  Endothelial cell function in diabetic microangiopathy.

Authors:  M Porta; M La Selva; P Molinatti; G M Molinatti
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

5.  Platelet sensitivity in vitro to adenosine-5'-diphosphate and prostacyclin and diabetic retinopathy.

Authors:  T M Davis; E Bown; R C Turner
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

6.  Platelet aggregability during the first two years of type 1 (insulin-dependent) diabetes mellitus in children.

Authors:  A M Kobbah; U Ewald; T Tuvemo
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

7.  Vasoreactivity and prostacyclin release in streptozotocin-diabetic rats: effects of insulin or aldose reductase inhibition.

Authors:  E J Stevens; G B Willars; P Lidbury; F House; D R Tomlinson
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  Plasma 6-keto-PGF1 alpha, thromboxane B2 and PGE2 in type 1 (insulin-dependent) diabetic patients during exercise.

Authors:  T Mourits-Andersen; I W Jensen; P N Jensen; J Ditzel; J Dyerberg
Journal:  Diabetologia       Date:  1987-07       Impact factor: 10.122

9.  Influence of glucose, insulin and sera from diabetic patients on the prostacyclin synthesis in vitro in cultured human endothelial cells.

Authors:  S Aanderud; H Krane; A Nordøy
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

10.  Is the variation in the susceptibility of various species to atherosclerosis due to inborn differences in prostacyclin (PGI2) formation.

Authors:  H Sinzinger; P Clopath; K Silberbauer; M Winter
Journal:  Experientia       Date:  1980-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.